A股異動 | 鼎勝新材(603876.SH)漲超4% 股東江蘇沿海減持期過半未減持
格隆匯12月26日丨鼎勝新材(603876.SH)現漲4.16%報43.29元,暫成交1.9億元,最新市值212億元。鼎勝新材上週五(23日)公佈,截至本公吿披露日,公司股東江蘇沿海減持計劃的減持時間過半。江蘇沿海未減持股份,本次減持計劃尚未實施完畢。國信證券曾發研報指,鼎勝新材是全球電池鋁箔龍頭,低成本疊加高良率構築業績支撐。公司處於快速成長期,明年隨着聯晟新材“年產80萬噸電池箔及配套坯料項目”的投產放量,電池鋁箔產銷量有望迎來大幅提升,且生產成本存在持續下降空間,首次覆蓋給予“買入”評級。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.